Skip to main content

Table 2 Non-hematologic toxicity by toxicity grade (NCI-CTC)

From: Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)

Toxicity 1 2 3 4
  No. % No. % No. % No. %
Anorexia 8 15.4 5 9.6 1 1.9 1 1.9
Nausea 11 21.2 2 3.8 1 1.9 0 0
Vomiting 5 9.6 1 1.9 1 1.9 0 0
Abdominal pain 4 7.7 4 7.7 1 1.9 0 0
Hot flushes 6 11.5 3 5.8 0 0 0 0
Sweating 7 13.5 4 7.7 0 0 0 0
Fatigue 9 17.3 9 17.3 2 3.8 0 0
Dizziness 5 9.6 1 1.9 1 1.9 0 0
Headache 4 7.7 2 3.8 0 0 0 0
Weight gain 4 7.7 1 1.9 0 0 0 0
Insomnia 5 9.6 4 7.7 0 0 0 0
Edema 3 5.8 1 1.9 0 0 0 0
Venous thrombosis 0 0 0 0 3 5.8 0 0